Salubris Pharmaceuticalsofficially Known As Shenzhen Salubris Pharmaceuticals Co Ltd Is An Innovation Driven Pharmaceutical Company Based In Shenzhenchinafounded In November 1998It Has Established Itself As A Significant Player In The Global Pharmaceutical Industrywith A Market Capitalization Of Approximately $4 4 Billion And Over 3 121 Employees As Of 2019The Company Reported Annual Sales Of $553 Million Salubris Pharmaceuticals Specializes In The Researchdevelopmentmanufactureand Distribution Of Pharmaceutical Productsits Product Pipeline Includes Drugs Aimed At Treating Metaboliconcologyand Bone Diseasessuch As Sacubitril Allisartan Calcium And Enarodustatthe Company Also Develops Interventional Medical Devices For Various Cardiovascular And Vascular Conditionswith A Global Presence In Countries Like The United Statesgermanyfranceand Japansalubris Leverages Diverse Markets To Advance Its Offerings
